Show
Sort by
-
Towards the use of interleukin-1β as vaccine adjuvant
-
A two-amino acid mutation in murine IgA enables downstream processing and purification on staphylococcal superantigen-like protein 7.
-
- Journal Article
- A1
- open access
Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface
-
Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses
-
- Journal Article
- A1
- open access
The role of matrix protein 2 ectodomain in the development of universal influenza vaccines
-
- Journal Article
- A1
- open access
Selective engagement of FcγRIV by a M2e-specific single domain antibody construct protects against influenza A virus infection
-
- Journal Article
- A1
- open access
Respiratory syncytial virus nonstructural proteins 1 and 2 : exceptional disrupters of innate immune responses
-
M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection
-
- Journal Article
- A1
- open access
Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy
-
Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
-
- Journal Article
- A1
- open access
Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ
-
Vaccine options for influenza : thinking small
-
- Journal Article
- A1
- open access
A respiratory syncytial virus vaccine based on the small hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults : a first-in-humans study
-
Transiently thermoresponsive acetal polymers for safe and effective administration of Amphotericin B as a vaccine adjuvant
-
- Journal Article
- A1
- open access
Porous nanoparticles with self-adjuvanting M2e-fusion protein and recombinant hemagglutinin provide strong and broadly protective immunity against influenza virus infections